³Ô¹ÏÍøÕ¾

Latest lung cancer News | Page 4

Immutep announces initiation of new breast cancer trial
Enhertu showed clinically meaningful and durable responses across multiple HER2-expressing tumour types in DESTINY-PanTumor02 Phase II trial
Ministers must act on killer stone at today’s crucial meeting
Passive vaping – time we see it like secondhand smoke and stand up for the right to clean air
Councils join together to crack down on retailers selling cigarettes to minors
Less lung tissue removal needed for early stage cancer
Immutep reaches enrolment target for INSIGHT-003 trial in first line NSCLC
World Cancer Day – Closing Care Gap
Dramatic rise in liver cancer in Australia’s tropical and equatorial north
Scientists detail major mechanism lung cancers use to evade immune attack
Does eating processed meats cause colorectal cancer?
ANU researchers closer to finding new lung cancer treatments
Expansion of Prescribed Cancers List for Firefighters
Govt Funds Lung Cancer Meds Keytruda & Tecentriq
More than $900,000 provided to support cancer specialists and help improve outcomes for patients
Govt’s medicines boost paying off for New Zealanders
More must be done to manage asbestos risks
New resources help employers better inform workers of asbestos risks
CFMEU launches rare action to ban deadly building material
Our Guide to Smoke-free Apartment Living
Asbestos: Deadly Legacy Lays Hidden In Plain Sight
Industry sector workers still being exposed to tobacco smoke and e-cig aerosols
Vaccination with senescent cells reduced tumor formation in mice
Research Excellence Awards 2022 winners
Lung cancer champion urges people to take symptom seriously
Annual Report 2021-22
Daffodil Centre, Cancer Council welcome MSAC advice on lung cancer screening
Low death rate, almost no flu but more alcohol-induced deaths in 2021: Australia
MSAC recommendation takes Australia one step closer to national lung cancer screening program
Expert advice on lung cancer screening
Second fast-track designation for Australian immunotherapy company
Imfinzi and tremelimumab with chemotherapy demonstrated sustained survival benefit
Enhertu continues to demonstrate clinically meaningful tumour response
Tagrisso demonstrated 5.5-year median disease-free survival in adjuvant treatment of patients with EGFR-mutated lung cancer
Two QUT scientists honoured with Qld Young Tall Poppy Science Award
Scientists unlock potential for small cell lung cancer blood test
Enhertu approved in US as first HER2-directed therapy for patients with previously treated HER2-mutant metastatic non-small cell
Datopotamab deruxtecan-based combinations show promising clinical activity
Radiopharm Theranostics announces new agreements with Lantheus and NanoMab
Broadly diverse genomes study reveals new susceptibility genetic variants for lung cancer
Broadly diverse genomes reveals new susceptibility genetic variants for lung cancer
Curtin University study backs AWU’s alarm at extent of workplace silicosis health risk
10,000 Aussie workers set to develop lung cancer from silica dust: study
Mapping ‘energy fingerprints’ of lung cancer leads to fundamental treatment rethink
Top 3 questions – Men’s Health Week with Dr Lucas de Toca
Company fined over crystalline silica exposure risk
NSW Government must act swiftly on silica recommendations
Collaboration to jumpstart research